FBRX
Forte Biosciences Inc.
$18.42
-$2.05(-10.00%)
80
Overall
60
Value
100
Tech
--
Quality
Market Cap
$124.95M
Volume
346.56K
52W Range
$4.90 - $28.68
Target Price
$63.33
Company Overview
| Mkt Cap | $124.95M | Price | $18.42 |
| Volume | 346.56K | Change | -10.00% |
| P/E Ratio | -3.5 | Open | $20.41 |
| Revenue | -- | Prev Close | $20.46 |
| Net Income | $-35.5M | 52W Range | $4.90 - $28.68 |
| Div Yield | N/A | Target | $63.33 |
| Overall | 80 | Value | 60 |
| Quality | -- | Technical | 100 |
No chart data available
Latest News
Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress
TipRanks Auto-Generated Newsdesk•9 days ago
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Forte Biosciences (FBRX)
Howard Kim•9 days ago
Forte Biosciences Advances Celiac Disease Treatment with FB102 Study
TipRanks Clinical-Trials-Auto-Generated Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FBRX | $18.42 | -10.0% | 346.56K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |